IRIS Institutional Research Information System - OPENBS Open Archive UniBS

DE PETRO, Giuseppina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.587
EU - Europa 6.398
AS - Asia 5.841
SA - Sud America 1.086
AF - Africa 125
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 23
AN - Antartide 1
Totale 22.084
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.385
CN - Cina 2.035
SG - Singapore 1.947
PL - Polonia 1.492
DE - Germania 1.159
UA - Ucraina 953
BR - Brasile 901
IT - Italia 803
HK - Hong Kong 508
FR - Francia 432
FI - Finlandia 428
VN - Vietnam 399
GB - Regno Unito 332
IN - India 304
RU - Federazione Russa 275
TR - Turchia 205
IE - Irlanda 158
CA - Canada 115
SE - Svezia 104
BD - Bangladesh 74
ID - Indonesia 74
AR - Argentina 71
MX - Messico 59
BE - Belgio 53
NL - Olanda 47
IQ - Iraq 42
JP - Giappone 42
ZA - Sudafrica 40
EC - Ecuador 35
AT - Austria 34
ES - Italia 34
PK - Pakistan 28
AU - Australia 21
EU - Europa 21
RO - Romania 20
SA - Arabia Saudita 20
CO - Colombia 18
KR - Corea 18
PY - Paraguay 17
JO - Giordania 15
KE - Kenya 15
AE - Emirati Arabi Uniti 14
IR - Iran 14
MA - Marocco 14
UZ - Uzbekistan 13
CH - Svizzera 12
CL - Cile 11
CZ - Repubblica Ceca 11
LT - Lituania 11
NG - Nigeria 11
VE - Venezuela 11
OM - Oman 10
AZ - Azerbaigian 9
IL - Israele 8
TH - Thailandia 8
BO - Bolivia 7
EG - Egitto 7
JM - Giamaica 7
KZ - Kazakistan 7
MU - Mauritius 7
PE - Perù 7
SD - Sudan 7
UY - Uruguay 7
CR - Costa Rica 6
DZ - Algeria 6
MY - Malesia 6
RS - Serbia 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
LY - Libia 5
TW - Taiwan 5
BH - Bahrain 4
PT - Portogallo 4
BG - Bulgaria 3
BY - Bielorussia 3
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
NP - Nepal 3
PA - Panama 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
AO - Angola 2
GE - Georgia 2
HN - Honduras 2
KG - Kirghizistan 2
LB - Libano 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
RE - Reunion 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
TM - Turkmenistan 2
Totale 22.063
Salva come PNG Salva come JPEG
Città #
Warsaw 1.488
Singapore 1.044
Ashburn 701
Jacksonville 673
Fairfield 605
Hong Kong 498
Woodbridge 469
Chandler 465
Beijing 429
Ann Arbor 391
The Dalles 360
Houston 318
San Jose 317
Wilmington 294
Princeton 288
Nanjing 266
Cambridge 263
Helsinki 256
New York 253
Seattle 238
Brescia 229
Los Angeles 201
Lauterbourg 161
Dublin 157
Dearborn 151
Istanbul 149
Ho Chi Minh City 131
Council Bluffs 126
Des Moines 110
Munich 107
Buffalo 104
Nanchang 91
Chicago 87
Milan 82
São Paulo 79
Moscow 76
Dallas 74
Shenyang 72
Dong Ket 70
Orem 70
Jinan 68
Hebei 67
Changsha 62
Shanghai 61
San Francisco 60
Redondo Beach 52
Tianjin 52
Hanoi 50
Brussels 49
Jiaxing 49
Jakarta 47
Lancaster 47
Santa Clara 44
Kunming 41
Toronto 37
Pune 35
Turku 35
Tokyo 34
Rio de Janeiro 33
Brooklyn 30
Chennai 30
Guangzhou 30
San Diego 30
Hangzhou 28
London 28
Lappeenranta 27
Salt Lake City 26
Verona 26
Zhengzhou 26
Johannesburg 25
Kocaeli 25
Amsterdam 24
Atlanta 24
Frankfurt am Main 24
Mexico City 24
Montreal 24
Mumbai 24
Nuremberg 23
Phoenix 22
Rome 20
Ningbo 18
North York 18
Denver 17
Nürnberg 17
Boardman 16
Manchester 16
Tampa 16
Vienna 16
Baghdad 15
Belo Horizonte 15
Boston 15
Charlotte 15
Da Nang 15
Amman 14
Bari 14
Brasília 14
Curitiba 14
Hefei 14
Porto Alegre 14
Stockholm 14
Totale 13.713
Salva come PNG Salva come JPEG
Nome #
Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis 348
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 319
Environment and bladder cancer: molecular analysis by interaction networks 317
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 308
Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis 285
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 263
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 258
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 250
RET/PTC-1-driven transformation and pro-invasive phenotype of human thyrocytes depend on MET induction and alpha-catenin nuclear translocation 241
Transmembrane protein TMEM230, regulator of metalloproteins and motor proteins in gliomas and gliosis 239
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 228
Functional Role of microRNA-23b-3p in Cancer Biology 220
Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers 219
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 218
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 218
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 213
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 212
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC 208
De novo 1Mb interstitial deletion of 8p22 in a patient with slight mental retardation and speech delay. 206
Biological Function of MicroRNA193a-3p in Health and Disease 205
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 204
miR103 e miR-107 sono coinvolti nella regolazione dell'espressione di CDK5R1/p35 implicato nella migrazione neuronale. 187
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC. 187
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC 184
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 182
Preparazione di colture primarie di fibroblasti di embrione di pollo . 181
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib 179
microRNAs and human hepatocellular carcinoma 176
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 172
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 171
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC 169
The study of HCC cell specific miRNas reveals one novel human miR and miR-21, miR24 and miR-27a differential expression in HCC 167
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 164
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC. 161
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 161
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 159
Determination of plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 157
RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: molecular markers for hepatocellular carcinoma 156
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 155
The analysis of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24, and miR-27a differential expression in cirrhotic/non- cirrhotic HCC. 151
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 149
Characterization of a 13 aminoacid human fibronectin peptide induce matrix assembly and inhibiting migration and invasion in tumor cells 148
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells. 148
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 147
Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy 145
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 143
Sequential analysis of multistage hepatocarcinogenesis reveals that miR100 and PLK1 dysregulation is an early event maintained along tumor progression. 143
FUNCTIONAL ROLE OF MICRORNA-23b-3p and MICRORNA-193a-3p IN CELL MIGRATION OF CANCER CELLS 143
Transformation enhancing activity present in the plasma of cancer patients binds to gelatin. 137
A rapid and highly sensitive solid phase enzyme immunoassay specific for human fibronectin using a characterized monoclonal antibody 136
Expression of Cellular and Extracellular TERRA, TERC and TERT in Hepatocellular Carcinoma 135
Transformation-enhancing activity of gelatin binding fragments of fibronectin 135
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 135
"Trasformazione indotta dai virus oncogeni ad RNA. Tecniche di produzione e titolazione del RSV in colture di fibroblasti di embrione di pollo" pp. 27- 34, settembre 1987, in: , CLEUP-Padova, Italia. 134
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK-1 dysregulation is an early event maintained along tumor progression. 133
DNA methylation variations in familial female and male breast cancer 133
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 131
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells 131
Matrix assembly induction and cell migration and invasion inhibition by a 13-amino acid fibronectin peptide 131
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 131
Gene response of human skin fibroblasts to urokinase- and tissue-type plasminogen activators. 130
miRNA Editing: New Insights into the Fast Control of Gene Expression in Health and Disease 130
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study 130
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. 129
Evidence for preferential proteolytic cleavage of one of the two fibronectin subunits and for immunological localization of a site distinguishing them 129
Urokinase and c-met are target of miR-23b in human cells. 128
Interaction of tissue type plasminogen activator with fibronectin and fibronectin fragments 127
Transformation enhancing activity in plasma of tumor patients: relationship with fibronectin fragments 125
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 125
Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients. 124
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 124
Androgen receptor mRNA under-expression in poorly differentiated human hepatocellular carcinoma. 123
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 122
Plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 121
Inhibition of Rous sarcoma virus-induced transformation by proteins involved in blood coagulation 121
Studi per lo sviluppo di terapie innovative molecolari per l’epatocarcinoma cellulare: microRNA e sorafenib. 121
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 120
Crosstalk Between DNA Methylation and Gene Mutations in Colorectal Cancer 119
Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts 118
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 118
Endocannabinoid system in inflammatory bowel diseases: mucosal gene expression preliminary data 117
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 117
Emerging role of Telomeric-Repeat containing RNA TERRA in hepatocellular carcinoma 117
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 116
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 116
Role of fibronectin degradation products on cellular transformation. 115
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 114
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 113
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 113
Circulating microRNA-23b-3p and tissue microRNA-193a-3p as promising molecular biomarkers in human hepatocellular carcinoma. 112
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 111
Conditional interactions of fibronectin: C-reactive protein, sulfated proteoglycans, and malignant transformation. 111
La trascrizione in Molecole, cellule e Organismi 111
Tecniche di conservazione delle cellule mediante congelamento. 110
Phosphorylation of human plasminogen activators and plasminogen. 109
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 109
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 109
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 108
Transformation enhancing factors and fibronectin degradation products as possible tumor markers. 108
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 107
Totale 15.893
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.880
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021495 0 0 0 0 0 0 0 0 0 203 180 112
2021/20221.186 62 215 56 73 10 41 49 68 67 127 130 288
2022/20231.248 186 64 35 123 119 296 13 104 187 10 48 63
2023/20241.308 95 31 137 75 63 274 83 46 233 53 28 190
2024/20253.527 41 64 66 462 326 306 283 119 442 186 802 430
2025/20266.012 600 850 477 935 626 518 880 255 394 477 0 0
Totale 22.440